Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2011

Jan 26, 2011

34975_dirs_2011-01-26_6ca28126-4d63-4507-996d-24dab2023c23.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2011-01-26

Reporting Person: LUSCINSKI SUSAN M (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-01-25 Common Stock F 5991 $4.08 Disposed 283259 Direct

Footnotes

F1: (1) The shares were disposed of to satisfy Ms. Luscinski's tax withholding obligation in connection with a deferred stock award granted to Ms. Luscinski on June 4, 2010 which vested in part on January 1, 2011.

F2: (2) Includes (a) a deferred stock award of 50,100 restricted stock units which vest in equal installments on Jan 1, 2012; January 1, 2013 and January 1, 2014; and (b) 233,159 shares of common stock held by Ms. Luscinski